Stem cell-based therapy can help those suffering from degenerative or genetic diseases such as Parkinson's, Alzheimer's, autism, diabetes, heart disease, stroke, spinal cord injuries, paralysis, blood-related diseases, cancer and burns, said Dr Anand S Shrivastava, director and co-founder, Global Institute of Stem Cell Therapy and Research (GIOSTAR), San Diego, California USA.
Known as the pioneer of modern stem cell science, Dr Shrivastava was delivering a talk on "Emerging Trends in Regenerative Medicine: Advances in Stem Cell Therapy" organised by the University of Science and Technology Meghalaya at the NKC Auditorium of the university here on Saturday.
Deven Patel, CEO and co-founder of GIOSTAR, made a presentation on the same theme on the occasion.
Prof Mohammed Basheer, former vice-chancellor of the University of Calicut, Kerala, Prof. GD Sharma, vice-chancellor, USTM apart from other dignitaries and students took part in the programme.
Addressing a large gathering of students, faculty members and officials of USTM, Dr Shrivastava said there are endless possibilities that one can treat any damage of organs through stem cell therapy.
According to him, metabolic diseases can be cured by stem cell treatment.
He also said that the cost of such a treatment is about Rs 3.5 lakh where the patient takes three doses in the interval of a certain time period.
Dr Shrivastava said his vision is to cure human diseases with regenerative medicine and to open globally stem cell-based therapy and research institutes.
Dr Shrivastava said his vision is to cure human diseases with regenerative medicine and to open globally stem cell-based therapy and research institutes.He also spoke about the potential of ES (embryonic stem) cells in brain repair as stem cells multiply and help in repairing damaged cells in the brain.
Dr Shrivastava's contribution in the field has been acknowledged by more than 18 Nobel laureates from across the world.
Speaking on the occasion, Patel said that GIOSTAR has been a leader in developing the most advanced stem cell-based technology, supported by leading scientists with pioneering publications in the area of stem cell biology.
"Its primary focus is to discover and develop a cure for human diseases with the state-of-the-art unique stem cell-based therapies and products. The regenerative medicine provides promise for the treatment of diseases previously regarded as incurable," he said.
GIOSTAR is the world's leading stem cell therapy and research institute and has been engaged in stem cell therapy and research work for over 20 years.
The enlightening talk was preceded by felicitation of guests where USTM honoured Dr Shrivastava with the 'Award of Excellence and Deven Patel with a 'Scroll of Honour'.
The enlightening talk was followed by an interaction with the audience.
Delivering the vote of thanks, USTM vice-chancellor Prof GD Sharma said that USTM was also planning to establish a stem cell centre.